Siegfried Holding AG SFZN.SW

Healthcare · Drug Manufacturers - Specialty & Generic · valued as of 2026-11-03 · statements 2025-12-31

Average Intrinsic Value
$2.19B
Market Cap
$3.87B
Margin of Safety
-76.7%
Intrinsic / Market Ratio
0.57

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

2.51B USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

2.82B USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

1.23B USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

2.19B USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

2.19B USD

from the sum above

Market Cap

3.87B USD

today's price times the shares

Intrinsic Value ÷ Market Cap

0.57×

the ratio the screener ranks by; Margin of Safety -76.7% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 2.51B USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)2.21B USD
+②Net Cash Today130.34M USD
+③Growth Value167.26M USD
=Value2.51B USD

EPV of the Operations (NOPAT over WACC)

2.21B USD

Net cash today

+130.34M USD

Growth Value

+167.26M USD

Value

2.51B USD

①EPV (earnings power value)

2.21B USD

②Net Cash Today

130.34M USD

③Growth Value

167.26M USD

Market value

Market Cap3.87B USD

Today's price times the shares.

Value vs market

Margin of Safety-54.0%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 2.82B USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE1.70B USD
+②Equity at Year 15, Today1.12B USD
=Value2.82B USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

1.70B USD

②Equity at Year 15, Today

1.12B USD

Market value

Market Cap3.87B USD

Today's price times the shares.

Value vs market

Margin of Safety-37.0%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 1.23B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).

The projection was not made (an FCFF at or below zero in the latest three years), so the value is the book value today, 1.23B USD, as the screener leaves it.

①Present Value of the 15 Years of FCFF

Not in the value

②Invested Capital at Year 15, Today

Not in the value

③Net Cash Today

Not in the value

Market value

Market Cap3.87B USD

Today's price times the shares.

Value vs market

Margin of Safety-213.8%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 9.25%
weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.79×Market Risk Premium 6.00%= 9.25%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 50.94M USDPretax Income 263.83M USD= 19.31%

The tax the interest saves.

Interest Expense =EBIT 272.81M USD−Pretax Income 263.83M USD= —

The interest the company paid: EBIT is the profit before tax plus the interest.

No interest is read: it needs debt and an EBIT above the profit before tax, the gap between them being the interest. Without it the cost of debt takes the 4% default.

Cost of Debt 4.00% (default): with no debt or no interest read, the 4% default after tax stands for what the lenders are paid a year.

Debt Weight =Total Debt 0 USDMarket Cap + Total Debt 3.87B USD + 0 USD= 0.00%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 100.00%×Cost of Equity 9.25%+Debt Weight 0.00%×Cost of Debt 4.00%= 9.25%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-06-30.

Total Assets 3.00B USD − Total Liabilities 1.76B USD = Book Value Today 1.23B USD

Total Debt 0 USD − Cash and Short-Term Investments 130.34M USD = Net Debt Today -130.34M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 13.2%at most 5%passes43,808,440 / 42,443,470
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets2.5%at least -10.0%passes(288.48M USD − 213.25M USD) ÷ 3.00B USD
Price to bookMarket Cap ÷ Book Value Today3.14×at most 3×does not pass3.87B USD ÷ 1.23B USD
Operating marginOperating Income ÷ Revenue16.3%above 10.0%passes273.44M USD ÷ 1.68B USD
Revenue growthRevenue ÷ Revenue a Year Before − 117.0%above 10.0%passes1.68B USD / 1.43B USD
Net cash(Cash − Total Debt) ÷ Market Cap3.4%above -30%passes(129.74M USD − 0 USD) ÷ 3.87B USD
Operating efficiencyOperating Income ÷ Gross Profit61.1%above 25.0%passes273.44M USD ÷ 447.58M USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Market data
The data provider's own ratios and the analysts' consensus, read beside the valuation, never in it.

Share price

73 USD

Enterprise value

4.02B USD

market cap plus net debt

EV / EBITDA

12.68×

Price / book

3.21×

the provider's book

Price / earnings

18.30×

Return on equity

17.0%

the provider's, not the engine's

Profit margin

12.8%

Revenue growth

2.2%

Analyst target, mean

101 USD

Analysts

12

opinions in the consensus

Financial Statements

The income statement, the balance sheet and the cash flow the screener holds, year by year, in USD.

Financial statements, year by year
The annual lines the screener holds today, in USD at each period's rate; the figures this valuation read are in its calculation above.
USD2022202320242025
Income statement

Revenue

1.33B1.51B1.43B1.68B

Gross profit

345.89M380.30M364.67M447.58M

Operating income

248.37M200.19M215.84M273.44M

EBITDA

operating income before depreciation and amortisation

334.21M286.08M320.83M392.62M

Pretax income

237.30M178.48M217.51M263.83M

Net income

169.74M133.85M177.39M213.25M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

168.35M130.83M173.33M205.59M

R&D

46.83M52.82M45.56M58.39M
Balance sheet, year end

Total assets

1.95B2.21B2.14B2.72B

Total liabilities

1.09B1.21B1.06B1.30B

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

857.91M994.92M1.09B1.43B

Total debt

————

Cash and equivalents

99.23M66.90M42.95M130.33M

Net PP&E

fixed assets after depreciation

845.95M950.81M1.01B1.28B

Working capital

current assets less current liabilities

680.41M694.78M701.26M662.55M
Cash flow

Operating cash flow

154.39M247.60M187.04M288.48M

Capital expenditure

paid out, so below zero

-124.96M-162.72M-200.42M-292.66M

Depreciation and amortisation

88.67M96.56M93.90M119.82M

Free cash flow

operating cash flow plus capital expenditure

29.43M84.88M-13.38M-4.19M